South Korea’s LG Chem announced that its cross-linked sodium hyaluronate gel with lidocaine has received marketing authorization from China’s National Medical Products Administration (NMPA). The product is distributed in China by Aiergi Health Technology (Beijing) Co., Ltd.
Product Application
The gel is approved for subcutaneous injection to the upper layer of the periosteum to correct midface volume loss and/or midface contour defects. This marks the first approval of a Korean cross-linked sodium hyaluronate gel for midface injection in China.-Fineline Info & Tech
